156 related articles for article (PubMed ID: 17284111)
21. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
22. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
23. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
24. CD44 is an independent prognostic factor in conventional renal cell carcinomas.
Paradis V; Ferlicot S; Ghannam E; Zeimoura L; Blanchet P; Eschwége P; Jardin A; Benoît G; Bedossa P
J Urol; 1999 Jun; 161(6):1984-7. PubMed ID: 10332486
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
[TBL] [Abstract][Full Text] [Related]
26. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib.
Terakawa T; Miyake H; Kusuda Y; Fujisawa M
Urol Oncol; 2013 May; 31(4):493-8. PubMed ID: 21478036
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 expression: does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?
Sozen S; Gurocak S; Erdem O; Acar C; Kordan Y; Akyol G; Alkibay T
Int Urol Nephrol; 2008; 40(2):295-301. PubMed ID: 17899436
[TBL] [Abstract][Full Text] [Related]
28. COX-2 Expression in Renal Cell Carcinoma and Correlations with Tumor Grade, Stage and Patient Prognosis.
Tabriz HM; Mirzaalizadeh M; Gooran S; Niki F; Jabri M
Asian Pac J Cancer Prev; 2016; 17(2):535-8. PubMed ID: 26925639
[TBL] [Abstract][Full Text] [Related]
29. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.
Bamias A; Chorti M; Deliveliotis C; Trakas N; Skolarikos A; Protogerou B; Legaki S; Tsakalou G; Tamvakis N; Dimopoulos MA
Urology; 2003 Aug; 62(2):368-73. PubMed ID: 12893366
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.
Zhang JP; Yuan HX; Kong WT; Liu Y; Lin ZM; Wangs WP; Guo JM
Tumour Biol; 2014 Dec; 35(12):12131-7. PubMed ID: 25142236
[TBL] [Abstract][Full Text] [Related]
33. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
Hofmockel G; Riess S; Bassukas ID; Dämmrich J
Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma.
Sulzbacher I; Birner P; Träxler M; Marberger M; Haitel A
Am J Clin Pathol; 2003 Jul; 120(1):107-12. PubMed ID: 12866380
[TBL] [Abstract][Full Text] [Related]
36. Analysis of CD44 isoform v10 expression and its prognostic value in renal cell carcinoma.
Li N; Tsuji M; Kanda K; Murakami Y; Kanayama H; Kagawa S
BJU Int; 2000 Mar; 85(4):514-8. PubMed ID: 10691836
[TBL] [Abstract][Full Text] [Related]
37. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
Lee C; Park JW; Suh JH; Moon KC
Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
[TBL] [Abstract][Full Text] [Related]
38. Neovascularity as a prognostic marker in renal cell carcinoma.
Bauman TM; Huang W; Lee MH; Abel EJ
Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
[TBL] [Abstract][Full Text] [Related]
40. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
